ADARx Pharmaceuticals (ADRX) vs Generate Biomedicines (GENB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
ADARx Pharmaceuticals is the larger company by market cap ($1.89 billion vs $1.80 billion), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ADRX | GENB |
|---|---|---|
| Share price | $17.68 | $13.99 |
| Market cap | $1.89B | $1.80B |
| 1-day change | +1.99% | +3.10% |
| EPS (TTM) | $-1.16 | $-2.44 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $23.21 | $22.67 |
| 52-week low | $16.64 | $11.00 |
| Distance from 52-week high | -23.85% | -38.29% |
| Analyst consensus | — | strong_buy |
| Avg. price target upside | — | +92.99% |
| Average volume | 1.25M | 1.05M |
| Shares outstanding | 106.80M | 128.35M |
| Employees | 100 | 312 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About ADARx Pharmaceuticals
ADRX stock →ADARx Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on developing siRNA therapeutics to treat a broad spectrum of diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 100 employees
About Generate Biomedicines
GENB stock →Generate Biomedicines, Inc., engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics in the United States. It uses protein-based modalities for drug development.
Health Care · Biotechnology: Pharmaceutical Preparations · 312 employees
ADRX vs GENB FAQ
Which is bigger, ADARx Pharmaceuticals or Generate Biomedicines?
ADARx Pharmaceuticals (ADRX) is larger, with a market capitalization of $1.89B compared with $1.80B for Generate Biomedicines (GENB).
Are ADARx Pharmaceuticals and Generate Biomedicines in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.